Keywords: pronova/gsk, omacor, reduces, death, chf, patients, lysaker

Pronova/GSK's Omacor reduces death in CHF patients

Article | 08 September 2008

Lysaker, Norway-based Pronova BioPharma's shares were up 3.1% at 23.2 Norwegian kroner on August 31, after the firm reported data from a Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

GSK

Go to company listing